Company registration number 12000217 (England and Wales)
PHARMIWEB.COM LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
PHARMIWEB.COM LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
PHARMIWEB.COM LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
3
404,690
704,735
Cash at bank and in hand
164,198
250,263
568,888
954,998
Creditors: amounts falling due within one year
4
(326,404)
(527,130)
Net current assets
242,484
427,868
Capital and reserves
Called up share capital
5
100
100
Profit and loss reserves
242,384
427,768
Total equity
242,484
427,868

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 31 October 2025 and are signed on its behalf by:
T Wood
Director
Company registration number 12000217 (England and Wales)
PHARMIWEB.COM LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

Pharmiweb.Com Limited is a private company limited by shares incorporated in England and Wales. The registered office is 1 Parkshot, Richmond, Surrey, TW9 2RD.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover represents net invoiced sales of services, excluding value added tax. Revenue is recognised depending on the type of service required either on delivery of access for single postings to the website or over the period for which access to the website has been granted.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

PHARMIWEB.COM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
8
9
PHARMIWEB.COM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
3
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
273,432
371,336
Amounts owed by group undertakings
130,128
315,711
Other debtors
1,130
17,688
404,690
704,735
4
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
11,009
18,783
Taxation and social security
49,761
132,285
Other creditors
265,634
376,062
326,404
527,130
5
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A of £1 each
100
100
100
100
6
Parent company

The parent company of Pharmiweb.Com Limited is Huumun Group Ltd and its registered office is 1 Parkshot, Richmond, TW9 2RD.

2024-12-31 2024-01-01 false false false 31 October 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity P Hartigan T Wood 12000217 2024-01-01 2024-12-31 12000217 2024-12-31 12000217 2023-12-31 12000217 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 12000217 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 12000217 core:ShareCapital 2024-12-31 12000217 core:ShareCapital 2023-12-31 12000217 core:RetainedEarningsAccumulatedLosses 2024-12-31 12000217 core:RetainedEarningsAccumulatedLosses 2023-12-31 12000217 core:ShareCapitalOrdinaryShareClass1 2024-12-31 12000217 core:ShareCapitalOrdinaryShareClass1 2023-12-31 12000217 bus:Director2 2024-01-01 2024-12-31 12000217 2023-01-01 2023-12-31 12000217 core:CurrentFinancialInstruments 2024-12-31 12000217 core:CurrentFinancialInstruments 2023-12-31 12000217 core:WithinOneYear 2024-12-31 12000217 core:WithinOneYear 2023-12-31 12000217 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 12000217 bus:OrdinaryShareClass1 2024-12-31 12000217 bus:OrdinaryShareClass1 2023-12-31 12000217 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12000217 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 12000217 bus:FRS102 2024-01-01 2024-12-31 12000217 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 12000217 bus:Director1 2024-01-01 2024-12-31 12000217 bus:FullAccounts 2024-01-01 2024-12-31 xbrli:pure xbrli:shares iso4217:GBP